Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daywin Patel

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Cardiovascular Toxicology|September 6, 2012
The dual-targeted HER1/HER2 tyrosine kinase inhibitor lapatinib strongly potentiates the cardiac myocyte-damaging effects of doxorubicinBrian B Hasinoff, Daywin Patel, Xing Wu
Cardiovascular Toxicology|November 28, 2019
The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent DexrazoxaneBrian B Hasinoff, Daywin Patel, Xing Wu
Cardiovascular Toxicology|July 9, 2016
Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and CarfilzomibBrian B Hasinoff, Daywin Patel, Xing Wu
Cardiovascular Toxicology|October 4, 2016
The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with SpecificityBrian B Hasinoff, Daywin Patel, Xing Wu
Molecular Pharmacology|August 16, 2003
The metabolites of the cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicityBrian B Hasinoff, Patricia E Schroeder, Daywin Patel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2008
The dihydroorotase inhibitor 5-aminoorotic acid inhibits the metabolism in the rat of the cardioprotective drug dexrazoxane and its one-ring open metabolitesPatricia E Schroeder, Daywin Patel, Brian B Hasinoff
Molecular Pharmacology|September 26, 2008
Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinibBrian B Hasinoff, Daywin Patel, Kimberley A O'Hara
Pediatric Surgery International|October 2, 2019
First steps in the development of a liquid biopsy in situ hybridization protocol to determine circular RNA biomarkers in rat biofluidsEimear Kirby, Wai Hei Tse, Daywin Patel, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 13, 2021
The RNA-binding protein Quaking regulates multiciliated and basal cell abundance in the developing lungDustin Ameis, Franklin Liu, Eimear Kirby, et al.
Journal of Inorganic Biochemistry|May 7, 2014
The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II)Brian B Hasinoff, Arun A Yadav, Daywin Patel, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Cardiovascular Toxicology|September 6, 2012
The dual-targeted HER1/HER2 tyrosine kinase inhibitor lapatinib strongly potentiates the cardiac myocyte-damaging effects of doxorubicinBrian B Hasinoff, Daywin Patel, Xing Wu
Cardiovascular Toxicology|November 28, 2019
The Role of Topoisomerase IIβ in the Mechanisms of Action of the Doxorubicin Cardioprotective Agent DexrazoxaneBrian B Hasinoff, Daywin Patel, Xing Wu
Cardiovascular Toxicology|July 9, 2016
Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and CarfilzomibBrian B Hasinoff, Daywin Patel, Xing Wu
Cardiovascular Toxicology|October 4, 2016
The Myocyte-Damaging Effects of the BCR-ABL1-Targeted Tyrosine Kinase Inhibitors Increase with Potency and Decrease with SpecificityBrian B Hasinoff, Daywin Patel, Xing Wu
Molecular Pharmacology|August 16, 2003
The metabolites of the cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicityBrian B Hasinoff, Patricia E Schroeder, Daywin Patel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 3, 2008
The dihydroorotase inhibitor 5-aminoorotic acid inhibits the metabolism in the rat of the cardioprotective drug dexrazoxane and its one-ring open metabolitesPatricia E Schroeder, Daywin Patel, Brian B Hasinoff
Molecular Pharmacology|September 26, 2008
Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinibBrian B Hasinoff, Daywin Patel, Kimberley A O'Hara
Pediatric Surgery International|October 2, 2019
First steps in the development of a liquid biopsy in situ hybridization protocol to determine circular RNA biomarkers in rat biofluidsEimear Kirby, Wai Hei Tse, Daywin Patel, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 13, 2021
The RNA-binding protein Quaking regulates multiciliated and basal cell abundance in the developing lungDustin Ameis, Franklin Liu, Eimear Kirby, et al.
Journal of Inorganic Biochemistry|May 7, 2014
The cytotoxicity of the anticancer drug elesclomol is due to oxidative stress indirectly mediated through its complex with Cu(II)Brian B Hasinoff, Arun A Yadav, Daywin Patel, et al.
Pageof 5